SCHEMBL3656289

SCHEMBL3656289

CC1=C[N]C(=O)C(=O)N1c1cccc(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
AR P10275 1/20 0.50
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HTT P42858 1/20 0.46
CFTR P13569 3/20 0.46
ALDH1A1 P00352 3/20 0.44
MAPT P10636 1/20 0.44
MDM2 Q00987 1/20 0.44
POLB P06746 1/20 0.44
CYP2C8 P10632 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PMM2 O15305 1/20 0.43
MPI P34949 1/20 0.43
PHOSPHO1 Q8TCT1 1/20 0.43
DPP4 P27487 1/20 0.42
BRD9 Q9H8M2 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17047686 0.79 AR (0.57) CYP1A2ARMEN1KMT2AHTT
SCHEMBL12327614 0.74 AR (0.50) CYP1A2ARMEN1KMT2AHTT
SCHEMBL29223913 0.73 AR (0.55) CYP1A2ARMEN1KMT2AHTT
SCHEMBL30900955 0.73 AR (0.55) CYP1A2ARMEN1KMT2AHTT
SCHEMBL11753893 0.72 MEN1 (0.54) CYP1A2ARMEN1KMT2AHTT
SCHEMBL12671928 0.72 DPP4 (0.58) CYP1A2ARMEN1KMT2AHTT
SCHEMBL3180022 0.72 MGLL (0.64) CYP1A2ARMEN1KMT2AHTT
SCHEMBL11611785 0.71 AR (0.52) CYP1A2ARMEN1KMT2AHTT
SCHEMBL5530144 0.71 NPC1 (0.58) CYP1A2ARMEN1KMT2AHTT
SCHEMBL14150069 0.71 DPP4 (0.50) CYP1A2ARMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217591-A1 SOME 2-PYRAZINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF NEUTROPHILE ELASTASE AstraZeneca AB (SE) 2010-08-18 EP disclosed
WO-2009061271-A1 SOME 2-PYRAZINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF NEUTROPHILE ELASTASE ASTRAZENECA AB (SE) 2009-05-14 WO disclosed
WO-2009058076-A1 2-PYRAZINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF NEUTROPHILE ELASTASE ASTRAZENECA AB (SE) 2009-05-07 WO disclosed
EP-2018377-A1 2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL. Astra Zeneca AB (SE) 2009-01-28 EP disclosed
WO-2007129963-A1 2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL. ASTRAZENECA AB (SE) 2007-11-15 WO disclosed